首页 | 本学科首页   官方微博 | 高级检索  
     

免疫清除性化疗结合自体外周血造血干细胞移植治疗重症系统性红斑狼疮
引用本文:王金铠,张金巧,李同健,张运清. 免疫清除性化疗结合自体外周血造血干细胞移植治疗重症系统性红斑狼疮[J]. 临床内科杂志, 2003, 20(3): 127-129
作者姓名:王金铠  张金巧  李同健  张运清
作者单位:050051,石家庄,河北医科大学第三医院血液科;050051,石家庄,河北医科大学第三医院血液科;050051,石家庄,河北医科大学第三医院血液科;050051,石家庄,河北医科大学第三医院血液科
摘    要:目的 观察免疫清除性化疗结合自体外周血造血干细胞移植(移植)治疗重症系统性红斑狼疮(SLE)的疗效及安全性。方法 重症SLE4例,分别合并狼疮性肾炎,狼疮脑,狼疮心或股骨头坏死,干细胞的动员采用环磷酰胺加重组人粒细胞集落因子(G-CSF);预处理为回输前3天每天应用环磷酰胺50mg/kg 回输后3天每天应用抗胸腺细胞球蛋白(ATG)5mg/kg。观察移植前后临床症状,体征,狼疮相关抗体等指标的改变,并动态观察移植后免疫功能的重建。结果 移植后患者的临床症状完全缓解,狼疮相关抗体全部转阴,移植后患者的免疫功能均明显降低,约半年后恢复正常,但不伴有临床症状的复发。结论 免疫清除性化疗结合自体外周血造血干细胞移对难治性SLE有明显的疗效,尤其适用对各种药物治疗无效者,治疗是安全的,远期疗效还需长期随访。

关 键 词:造血干细胞移植  系统性红斑狼疮/治疗
文章编号:1001-9057(2003)03-0127-03
修稿时间:2002-03-21

Immunoablative chemotherapy with autologous peripheral blood stem cell rescule in patients with severe systemic lupus erythematosus
WANG Jinkai,ZHANG Jinqiao,LI Tong Jian,et al.. Immunoablative chemotherapy with autologous peripheral blood stem cell rescule in patients with severe systemic lupus erythematosus[J]. Journal of Clinical Internal Medicine, 2003, 20(3): 127-129
Authors:WANG Jinkai  ZHANG Jinqiao  LI Tong Jian  et al.
Affiliation:WANG Jinkai,ZHANG Jinqiao,LI Tong Jian,et al. Department of Hematology,The third affiliated hospital of HeBei Medical University. Shijiazhuang 050051,China
Abstract:Objective To study the clinical effect of immunoablative chemotherapy with autologous peripheral blood stem cell rescule in patients with severe systemic lupus erythematosus (SLE).Methods Four severe SLE were chosen. Peripheral blood stem cell (PBSCs) were mobilized with CTX and granulocyte colony-stimulating factor (G CSF). PBSCs were reinfused after conditioned by CTX (50mg/kg every day for 3 days) + Antithymocyte globulin (5mg/kg every day for 3 days). Both clinical manifestations and lupus -correlated antigens were compared before and after transplantation. The reconstrution of immune function were observed.Results After transplantation the patients received clinical remission and immunologic abnormality returned to normal. Immune function decreased remarkably after the transplantation and resumed to normal about 6 months after the transplantation.Conclusion APBSCT is effective and safety for severe SLE. It is required to follow-up for evaluation long-term effect.. [
Keywords:Haematopoietic stem cell transplantation  Systemic lupus erythematosus/therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号